Back
Moleculin Biotech Vs. Cara Therapeutics Industry Stock Comparison
Sell
15
MBRX
Moleculin Biotech
Last Price:
2.40
Seasonality Move:
-16.57%
Sell
17
CARA
Cara Therapeutics
Last Price:
0.30
Seasonality Move:
-5.78%
Sell
15
Moleculin Biotech (MBRX)
is a Sell
Is Moleculin Biotech a Buy, Sell or Hold?
- The current Moleculin Biotech [MBRX] share price is $2.40. The Score for MBRX is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
- MBRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
17
Cara Therapeutics (CARA)
is a Sell
Is Cara Therapeutics a Buy, Sell or Hold?
- The current Cara Therapeutics [CARA] share price is $0.31. The Score for CARA is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- CARA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
MBRX Stock Price Chart
What is Moleculin Biotech's stock price today?
-
The Moleculin Biotech share price today is $2.40
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MBRX is experiencing slight selling pressure.
CARA Stock Price Chart
What is Cara Therapeutics's stock price today?
-
The Cara Therapeutics share price today is $0.31
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CARA is experiencing buying pressure, which is a positive indicator for future bullish movement.
MBRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 44.06 | Sell |
Chaikin Money Flow: | -8010 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.36 - 2.52) | Sell |
Bollinger Bands (100): | (2.59 - 4.63) | Sell |
CARA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 48.11 | Sell |
Chaikin Money Flow: | 226620 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.29 - 0.35) | Sell |
Bollinger Bands (100): | (0.26 - 0.64) | Sell |
MBRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.4 | Sell |
20-day SMA: | 2.44 | Sell |
50-day SMA: | 2.84 | Sell |
200-day SMA: | 5.78 | Sell |
8-day EMA: | 2.41 | Sell |
20-day EMA: | 2.45 | Sell |
50-day EMA: | 2.83 | Sell |
200-day EMA: | 5.27 | Sell |
CARA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.28 | Buy |
20-day SMA: | 0.32 | Sell |
50-day SMA: | 0.34 | Sell |
200-day SMA: | 0.61 | Sell |
8-day EMA: | 0.29 | Buy |
20-day EMA: | 0.31 | Buy |
50-day EMA: | 0.35 | Sell |
200-day EMA: | 0.93 | Sell |
Moleculin Biotech Earnings Growth & MBRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.06 per share, and an increase next year of $8.81 per share.
Cara Therapeutics Earnings Growth & CARA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and an increase next year of $0.52 per share.
Moleculin Biotech Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cara Therapeutics Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |